Black Diamond Therapeutics
BDTX
BDTX
59 hedge funds and large institutions have $37.8M invested in Black Diamond Therapeutics in 2022 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 26 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
50% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 18
69% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 26
Holders
59
Holding in Top 10
–
Calls
$50K
Puts
$77K
Top Buyers
| 1 | +$1.32M | |
| 2 | +$1.23M | |
| 3 | +$508K | |
| 4 |
Millennium Management
New York
|
+$320K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$95K |
Top Sellers
| 1 | -$1.57M | |
| 2 | -$544K | |
| 3 | -$486K | |
| 4 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$389K |
| 5 |
Morgan Stanley
New York
|
-$356K |